Abstract
Background: Flurandrenolide tape has recently been listed as a group I topical cortico-steroid. There are no studies that compare this product to group I ointments in the treatment of steroid-responsive dermatoses. Objective: Our purpose was to determine the relative efficacy of flurandrenolide (4 mg/cm 2 ) tape versus 0.05% diflorasone diacetate ointment in plaque psoriasis. Methods: Thirty patients participated in an investigator-blinded, randomized, bilateral paired-comparison study of flurandrenolide tape applied to lesions of one side of the body once daily for up to 16 hours versus diflorasone diacetate ointment applied contralaterally twice daily. Lesions were assessed at baseline, then reevaluated at 2 and 4 weeks. Results: Flurandrenolide tape–treated plaques showed consistently greater clearing in terms of erythema, scaling, induration, and treatment success for all plaques, as well as the subset of knee and elbow plaques, when compared with the lesions receiving diflorasone diacetate ointment. Conclusion: The efficacy of flurandrenolide tape in the treatment of psoriatic plaques surpasses that of diflorasone diacetate ointment. (J Am Acad Dermatol 1998;38:186-90.)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
